LNTH Q1 2018 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$83M+1.6% YoY

Gross Profit

$42M51.2% margin

Operating Income

$15M18.3% margin

Net Income

$8M9.9% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

-$666,000

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$393M

Total Liabilities

$359M

Stockholders' Equity

$34M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$81M	+1.6%
Gross Profit	$42M	$40M	+6.4%
Operating Income	$15M	$12M	+26.9%
Net Income	$8M	$4M	+98.4%

Revenue Segments

Product Revenue, Net

$82M99%

License and Royalty Revenues

$562,0001%